{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:15:59Z","timestamp":1780337759924,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1919-6","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:03:43Z","timestamp":1559055823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study"],"prefix":"10.1186","volume":"21","author":[{"given":"Kazuki M.","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Kuzumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takemichi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayakazu","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/1346-8138.14153","volume":"45","author":"Y Asano","year":"2018","unstructured":"Asano Y. Systemic sclerosis. J Dermatol. 2018;45:128\u201338.","journal-title":"J Dermatol"},{"issue":"1","key":"1919_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","volume":"37","author":"M Jinnin","year":"2010","unstructured":"Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37(1):11\u201325.","journal-title":"J Dermatol"},{"issue":"2","key":"1919_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00005382-199203000-00005","volume":"7","author":"AC Arroliga","year":"1992","unstructured":"Arroliga AC, Podell RAM DN. Pulmonary manifestations of scleroderma. J Thorac Imaging. 1992;7(2):30\u201345.","journal-title":"J Thorac Imaging"},{"key":"1919_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2017.11.020","volume":"17","author":"D Giuggioli","year":"2018","unstructured":"Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C. Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev. 2018;17:155\u201364.","journal-title":"Autoimmun Rev"},{"key":"1919_CR5","doi-asserted-by":"publisher","first-page":"iii32","DOI":"10.1093\/rheumatology\/ken483","volume":"48","author":"CP Denton","year":"2006","unstructured":"Denton CP, Lapadula G, Mouthon L, M\u00fcller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology. 2006;48:iii32\u20135.","journal-title":"Rheumatology."},{"key":"1919_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1445-5994.2007.01370.x","volume":"37","author":"SM Proudman","year":"2007","unstructured":"Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J. 2007;37:485\u201394.","journal-title":"Intern Med J"},{"issue":"1","key":"1919_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","volume":"37","author":"Y Hamaguchi","year":"2010","unstructured":"Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37(1):42\u201353.","journal-title":"J Dermatol"},{"issue":"2","key":"1919_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"6","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Denton CP. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol. 2010;6(2):112\u20136.","journal-title":"Nat Rev Rheumatol"},{"key":"1919_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00300808","volume":"14","author":"B Sharada","year":"1994","unstructured":"Sharada B, Kumar A, Kakker R, Adya CM, Pande I, Uppal SS, et al. Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis - a randomized placebo-controlled study. Rheumatol Int. 1994;14:91\u20134.","journal-title":"Rheumatol Int"},{"key":"1919_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.resinv.2012.12.002","volume":"51","author":"K Ando","year":"2013","unstructured":"Ando K, Motojima S, Doi T, Nagaoka T, Kaneko N, Aoshima M, et al. Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease. Respir Investig. 2013;51:69\u201375.","journal-title":"Respir Investig"},{"key":"1919_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","volume":"76","author":"VD Steen","year":"1984","unstructured":"Steen VD, Medsger TA, Osial TA, Ziegler GL, Alvin Shapiro BP, Rodnan GP. Factors predicting development of renal involvement progressive systemic sclerosis. Am J Med. 1984;76:779\u201386.","journal-title":"Am J Med"},{"issue":"9","key":"1919_CR12","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/anr.1780320911","volume":"32","author":"DJ Helfrich","year":"1989","unstructured":"Helfrich DJ, Banner B, Steen VD, Medsger TA. Normotensive renal failure in systemic sclerosis. Arthritis Rheum. 1989;32(9):1128\u201334.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1919_CR13","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","volume":"44","author":"AE Thompson","year":"2001","unstructured":"Thompson AE, Shea B, Welch V, Fenlon D, Pope JE. Calcium-channel blockers for Raynaud\u2019s phenomenon in systemic sclerosis. Arthritis Rheum. 2001;44(8):1841\u20137.","journal-title":"Arthritis Rheum"},{"key":"1919_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF00314958","volume":"41","author":"I Konrad-Dalhoff","year":"1991","unstructured":"Konrad-Dalhoff I, Baunack AR, R\u00e4msch KD, Ahr G, Kraft H, Schmitz H, et al. Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J Clin Pharmacol. 1991;41:313\u20136.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1919_CR15","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/art.1780330828","volume":"33","author":"PJ Clements","year":"1990","unstructured":"Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33(8):1256\u201363.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1919_CR16","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","volume":"45","author":"PJ Clements","year":"2000","unstructured":"Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum. 2000;45(11):2445\u201354.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1919_CR17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/acr.22339","volume":"66","author":"AB Wiese","year":"2014","unstructured":"Wiese AB, Berrocal VJ, Furst DE, Seibold JR, Merkel PA, Mayes MD, et al. Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis. Arthritis Care Res. 2014;66(11):1731\u20139.","journal-title":"Arthritis Care Res"},{"issue":"8","key":"1919_CR18","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/art.24681","volume":"60","author":"S Amjadi","year":"2009","unstructured":"Amjadi S, Maranian P, Furst DE, Clements PJ, Weng KW, Postlethwaite AE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum. 2009;60(8):2490\u20138.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1919_CR19","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1002\/art.22721","volume":"56","author":"L Shand","year":"2007","unstructured":"Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum. 2007;56(7):2422\u201331.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1919_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/1529-0131(200103)44:3<653::AID-ANR114>3.0.CO;2-Q","volume":"44","author":"PJ Clements","year":"2001","unstructured":"Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. The disability index of the health assessment questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum. 2001;44(3):653\u201361.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1919_CR21","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/1529-0131(199911)42:11<2372::AID-ANR16>3.0.CO;2-J","volume":"42","author":"PJ Clements","year":"1999","unstructured":"Clements PJ, Wong K, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum. 1999;42(11):2372\u201380.","journal-title":"Arthritis Rheum"},{"key":"1919_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/ard.2009.127621","volume":"70","author":"RT Domsic","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis. 2011;70:104\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1919_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11\u20138.","journal-title":"J Scleroderma Relat Disord"},{"issue":"11","key":"1919_CR24","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"1919_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","volume":"111","author":"D Armstrong","year":"1996","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche P, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85\u201392.","journal-title":"Gastroenterology."},{"key":"1919_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/ard.2006.066530","volume":"66","author":"L Czirjak","year":"2007","unstructured":"Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-cerinic M, Furst DE. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rhem Dis. 2007;66:966\u20139.","journal-title":"Ann Rhem Dis"},{"issue":"11","key":"1919_CR27","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437\u201344.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1919_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5021\/ad.2015.27.1.1","volume":"27","author":"A Yoshizaki","year":"2015","unstructured":"Yoshizaki A, Sato S. Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol. 2015;27(1):1\u20139.","journal-title":"Ann Dermatol"},{"issue":"3","key":"1919_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","volume":"169","author":"M Hasegawa","year":"2006","unstructured":"Hasegawa M, Hamaguchi Y, Yanaba K, Bouaziz JD, Uchida J, Fujimoto M, et al. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol. 2006;169(3):954\u201366.","journal-title":"Am J Pathol"},{"issue":"1","key":"1919_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/ard.2008.095463","volume":"69","author":"V Smith","year":"2010","unstructured":"Smith V, Van Praet JT, Vandooren B, Van Der Cruyssen B, Naeyaert JM, Decuman S, et al. Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis. 2010;69(1):193\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1919_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis S-NC, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, et al. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rhematology (Oxford). 2010;49:271\u201380.","journal-title":"Rhematology (Oxford)"},{"key":"1919_CR32","first-page":"17","volume":"30","author":"D Daoussis","year":"2012","unstructured":"Daoussis D, Liossis S-NC, Tsamandas Christina Kalogeropoulou AC, Paliogianni F, Sirinian C, Yiannopoulos G, et al. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol. 2012;30:17\u201322.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1919_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.semarthrit.2016.10.003","volume":"46","author":"D Daoussis","year":"2017","unstructured":"Daoussis D, Melissaropoulos K, Sakellaropoulos G, Antonopoulos I, Markatseli TE, Simopoulou T, et al. A multicenter, open-label, comparative study of B-cell depletion therapy with rituximab for systemic sclerosis-associated interstitial lung disease. Semin Arthritis Rheum. 2017 Apr;46(5):625\u201331.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1919_CR34","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","volume":"74","author":"S Jordan","year":"2015","unstructured":"Jordan S, Distler JHW, Maurer B, Huscher D, Van Laar JM, Allanore Y, et al. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis. 2015;74(6):1188\u201394.","journal-title":"Ann Rheum Dis"},{"key":"1919_CR35","first-page":"697","volume":"29","author":"A Snir","year":"2011","unstructured":"Snir A, Kessel A, Haj T, Rosner I, Slobodin G, Toubi E, et al. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Ecp Rheumatol. 2011;29:697\u2013700.","journal-title":"Ecp Rheumatol"},{"issue":"63","key":"1919_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/art.30242","volume":"2011","author":"P Roll","year":"2011","unstructured":"Roll P, Muhammad K, Schumann M, Kleinert S, Einsele H, D\u00f6rner T, et al. In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment. Arthritis Rheum. 2011;2011(63):1255\u201364.","journal-title":"Arthritis Rheum"},{"key":"1919_CR37","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","volume":"387","author":"D Khanna","year":"2016","unstructured":"Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet. 2016;387:2630\u201340.","journal-title":"Lancet."},{"issue":"2","key":"1919_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","volume":"77","author":"D Khanna","year":"2018","unstructured":"Khanna D, Denton CP, Lin CJF, Van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Ann Rheum Dis. 2018;77(2):212\u201320.","journal-title":"Ann Rheum Dis"},{"key":"1919_CR39","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes MCD. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281\u20135.","journal-title":"J Rheumatol"},{"issue":"2","key":"1919_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/acr.22804","volume":"68","author":"D Khanna","year":"2016","unstructured":"Khanna D, Berrocal VJ, Giannini EH, Seibold JR, Merkel PA, Mayes MD, et al. The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis. Arthritis Care Res. 2016;68(2):167\u201378.","journal-title":"Arthritis Care Res"},{"issue":"12","key":"1919_CR41","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/art.39405","volume":"67","author":"YA Suliman","year":"2015","unstructured":"Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, et al. Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67(12):3256\u201361.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1919_CR42","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"E Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005;52(12):3792\u2013800.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1919_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/rheumatology\/28.4.281","volume":"28","author":"BYA Akesson","year":"1989","unstructured":"Akesson BYA, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol. 1989;28(4):281\u20136.","journal-title":"Br J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1919-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1919-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:24:16Z","timestamp":1590535456000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1919-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1919-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee at The University of Tokyo Hospital. Informed consent was obtained on document from the subject patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}